Bruce Bode Selected Research

Bruce Bode Research Topics

Disease

31	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2022 - 03/2002
19	Hypoglycemia (Reactive Hypoglycemia) 01/2021 - 04/2004
15	Type 2 Diabetes Mellitus (MODY) 12/2021 - 02/2005
6	Hyperglycemia 07/2020 - 04/2004
5	Body Weight (Weight, Body) 10/2016 - 04/2013
3	COVID-19 11/2022 - 07/2020
3	Diabetes Complications 12/2021 - 04/2011
3	Weight Loss (Weight Reduction) 01/2019 - 03/2011
3	Weight Gain 02/2009 - 02/2005
2	Injection Site Reaction 12/2021 - 01/2021
2	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2021 - 01/2015
2	Peripheral Nervous System Diseases (PNS Diseases) 10/2021 - 01/2021
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2021 - 08/2015
2	Inflammation (Inflammations) 01/2021 - 11/2011
2	Obesity 02/2019 - 08/2015
2	Nausea 01/2019 - 11/2014
2	Urinary Tract Infections (Urinary Tract Infection) 04/2014 - 04/2013
2	Infections 04/2014 - 04/2013
1	Chronic Disease (Chronic Diseases) 06/2022
1	Coma (Comas) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Ketosis 10/2016
1	Overweight 08/2015
1	Diabetes Mellitus 12/2013
1	Polyuria 04/2013
1	Exanthema (Rash) 08/2011
1	Disease Progression 03/2011
1	Vomiting 02/2009

Drug/Important Bio-Agent (IBA)

27	Insulin (Novolin)FDA Link 06/2022 - 03/2002
21	Glucose (Dextrose)FDA LinkGeneric 06/2022 - 03/2004
7	Liraglutide FDA Link 01/2021 - 02/2009
7	Insulin Glargine (Lantus)FDA Link 11/2020 - 02/2005
7	Insulin Aspart (NovoLog)FDA Link 01/2019 - 03/2002
6	Insulin Lispro (Humalog)FDA Link 12/2021 - 03/2002
6	Hypoglycemic Agents (Hypoglycemics)IBA 11/2019 - 04/2004
5	Hemoglobins (Hemoglobin)IBA 11/2022 - 04/2004
4	insulin degludecIBA 11/2020 - 04/2012
4	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2019 - 03/2011
4	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 03/2016 - 03/2011
4	Metformin (Glucophage)FDA LinkGeneric 08/2015 - 01/2007
3	Blood Glucose (Blood Sugar)IBA 12/2021 - 01/2007
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2019 - 07/2010
3	SymportersIBA 03/2016 - 04/2013
3	SodiumIBA 03/2016 - 04/2013
3	CanagliflozinIBA 03/2016 - 04/2013
2	Blood Proteins (Serum Proteins)IBA 09/2015 - 11/2011
2	IncretinsIBA 07/2012 - 07/2010
2	Monoclonal AntibodiesIBA 08/2011 - 08/2010
1	Glucagon (Glukagon)FDA Link 01/2022
1	Retinaldehyde (Retinal)IBA 11/2021
1	NAD (NADH)IBA 10/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2021
1	(L)-Isomer Glucose (L-Glucose)IBA 01/2020
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2019
1	semaglutideIBA 01/2019
1	Quick-SetIBA 01/2018
1	hydroxide ionIBA 01/2017
1	Insulin-Like Growth Factor Binding Protein 3IBA 01/2016
1	CytokinesIBA 09/2015
1	Interleukin-8 (Interleukin 8)IBA 09/2015
1	ChemokinesIBA 09/2015
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 09/2015
1	2,4-thiazolidinedione (thiazolidinedione)IBA 08/2015
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2015
1	Pioglitazone (Actos)FDA Link 11/2014
1	IDegLiraIBA 11/2014
1	AutoantibodiesIBA 09/2013
1	LDL CholesterolIBA 04/2013
1	Triglycerides (Triacylglycerol)IBA 04/2013
1	HDL CholesterolIBA 04/2013
1	insulin aspart drug combination insulin degludecIBA 11/2012
1	ProteomeIBA 11/2011
1	teplizumabIBA 08/2011
1	Fc Receptors (Fc Receptor)IBA 08/2011
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2011
1	Hemoglobin AIBA 03/2011
1	Dipeptidyl-Peptidase IV InhibitorsIBA 03/2011
1	Hormones (Hormone)IBA 07/2010
1	Insulin Detemir (Levemir)FDA Link 10/2009
1	glimepiride (Amarel)FDA LinkGeneric 02/2009
1	insulin aspart protamine drug combination 30:70 insulin aspartIBA 01/2007
1	ThiazolidinedionesIBA 01/2007

Therapy/Procedure

14	Therapeutics 06/2022 - 12/2004
10	Glycemic Control 01/2021 - 10/2009
2	Injections 11/2014 - 11/2012
1	Ambulatory Care (Outpatient Care) 01/2021
1	Length of Stay 07/2020